Vontobel Holding Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Vontobel Holding Ltd.

  • $29.2 Billion
  • Q3 2024

A detailed history of Vontobel Holding Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 4,136 shares of REGN stock, worth $3.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,136
Previous 4,403 6.06%
Holding current value
$3.08 Million
Previous $4.63 Million 6.05%
% of portfolio
0.01%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
SELL
$1024.09 - $1201.76 $273,432 - $320,869
-267 Reduced 6.06%
4,136 $4.35 Million
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $603,225 - $731,622
683 Added 18.36%
4,403 $4.63 Million
Q1 2024

May 10, 2024
SELL
$902.69 - $993.35 $3.06 Million - $3.37 Million
-3,388 Reduced 47.66%
3,720 $3.58 Million
Q4 2023

Jun 03, 2024
SELL
$775.18 - $881.7 $2.99 Million - $3.4 Million
-3,855 Reduced 44.46%
4,815 $4.23 Million
Q4 2023

Jan 29, 2024
SELL
$775.18 - $881.7 $2.99 Million - $3.4 Million
-3,858 Reduced 35.18%
7,108 $6.24 Million
Q3 2023

Jun 03, 2024
BUY
$692.45 - $844.37 $1.15 Million - $1.41 Million
1,665 Added 23.77%
8,670 $7.14 Million
Q3 2023

Oct 10, 2023
BUY
$692.45 - $844.37 $1.51 Million - $1.84 Million
2,174 Added 24.73%
10,966 $9.02 Million
Q2 2023

Jun 03, 2024
SELL
$700.03 - $830.35 $70,703 - $83,865
-101 Reduced 1.42%
7,005 $5.03 Million
Q2 2023

Jul 24, 2023
SELL
$700.03 - $830.35 $114,104 - $135,347
-163 Reduced 1.82%
8,792 $6.32 Million
Q1 2023

Jun 03, 2024
BUY
$680.49 - $826.97 $2.3 Million - $2.8 Million
3,386 Added 91.02%
7,106 $5.84 Million
Q1 2023

Apr 12, 2023
BUY
$680.49 - $826.97 $585,901 - $712,021
861 Added 10.64%
8,955 $7.36 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $1.53 Million - $1.66 Million
2,167 Added 36.56%
8,094 $5.84 Million
Q3 2022

Nov 04, 2022
SELL
$573.97 - $724.32 $251,398 - $317,252
-438 Reduced 6.88%
5,927 $4.08 Million
Q2 2022

Jul 27, 2022
SELL
$548.35 - $738.84 $650,343 - $876,264
-1,186 Reduced 15.71%
6,365 $3.8 Million
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $2.5 Million - $2.93 Million
-4,197 Reduced 35.73%
7,551 $5.23 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $878,263 - $1.08 Million
-1,616 Reduced 12.09%
11,748 $7.55 Million
Q3 2021

Oct 29, 2021
BUY
$574.03 - $680.96 $316,290 - $375,208
551 Added 4.3%
13,364 $8.09 Million
Q2 2021

Aug 06, 2021
SELL
$472.8 - $558.54 $581,544 - $687,004
-1,230 Reduced 8.76%
12,813 $7 Million
Q1 2021

May 11, 2021
BUY
$446.73 - $548.2 $366,318 - $449,524
820 Added 6.2%
14,043 $6.65 Million
Q4 2020

Feb 12, 2021
BUY
$478.3 - $607.98 $6.32 Million - $8.04 Million
13,223 New
13,223 $6.54 Million

Others Institutions Holding REGN

# of Institutions
1,531
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email